Available Until 3/23/2026

Controlled Substance Diversion Prevention for Pharmacy Technicians

ACPE Numbers: Various – see listing below
Content Release Date:03/23/2023
Expiration Date: 03/23/2026
Activity Type: Knowledge-based
CE Credits: 3.25 hours (ACPE only)
Activity Fee: $59 (ASHP member); $89 (non-member)

Activity Overview

This online course provides a robust curriculum for learning about controlled substances diversion prevention. Designed based on the domains, tasks, and knowledge statements developed by PTCB for their Assessment-Based Certificate Program in Controlled Substances Diversion Prevention, this course will teach you by:

  • Reviewing pertinent topics and tools and skills
  • Providing exam practice questions
  • Listing valuable references for further study

This online course consists of 4 activities (see tables below) and provides up to 3.25 hours of continuing pharmacy education credit.

These activities are part of the ASHP professional development program.

Activity Overview

This course consists of four activities (see table below) and provides up to 3.25 hours of continuing pharmacy education credit. The review course includes instructional home-study modular webinars, and practice questions exam along with correct answers, and links to the reference sources, and domains, tasks, and knowledge statements.

Learning Module

ACPE Number

Credit Hours

ACPE Expiration Date

Controlled Substance Diversion overview




Controlled Substance Diversion Prevention



Drug Enforcement Agency Requirements



Surveillance and Investigation




The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Target Audience

These activities are intended for pharmacy technicians who are seeking to update their knowledge and skills regarding controlled substances diversion prevention. This program is a PTCB-Recognized Education/Training Program for their Controlled Substances Diversion Prevention Assessment-Based Certificate Program.

After participating in this CPE activity, learners should be able to:

Controlled Substance Diversion overview

ACPE Number: 0204-0000-23-077-H04-T

  • Discuss the consequences of controlled substance (CS) diversion.
  • Describe the signs of an impaired health-care worker.
  • Explain the motivations to divert CS.

Controlled Substance Diversion Prevention

ACPE Number: 0204-0000-23-078-H04-T

  • List areas of vulnerability in procurement, preparation and dispensing, prescribing, administration, and waste/removal processes.
  • Discuss the elements of a comprehensive and effective controlled substances diversion prevention program (CSDPP).
  • Explain the types and functions of security control measures, devices, and software to detect and prevent diversion.
  • Recognize the high-risk areas of the pharmacy and other departments.
  • Describe chain of custody methods as they relate to CS.

Drug Enforcement Agency Requirements

ACPE Number: 0204-0000-23-079-H03-T

  • Discuss DEA registration requirements.
  • Review the contents, appropriate usage, and record keeping for all applicable DEA forms.
  • Explain the DEA Controlled Substance Ordering System (CSOS).
  • Explain the DEA controlled substance list including those that are at a high risk for diversion.
  • List the DEA requirements for conducting physical inventories and record keeping.
  • Describe the actions to take during a robbery or theft event.
  • Recognize the procedures required for sales of CS and restricted OTCs.

Surveillance and Investigation

ACPE Number: 0204-0000-23-080-H04-T

  • Recognize suspicious data patterns as they relate to CS.
  • Explain surveillance practices and techniques.
  • Describe signs of product tampering and/or alteration.
  • Recognize signs of and methods to detect fraudulent prescriptions.


Matthew Rewald, CPhT
Program Director- MCSHS Pharmacy Technician Program
Assistant Professor of Pharmacy – Mayo College of Medicine
Pharmacy Technician Education Coordinator – Mayo Clinic
Rochester, Minnesota 

Edna Bowser, CPhT
Pharmacy Technician
VA Butler Healthcare
Butler, Pennsylvania 

Rebecca Bryan, CPhT, RHIT
Pharmacy Manager, Pharmacy Services
Gundersen Health System
La Crosse Wisconsin

Allison Rose, CPhT
Senior Project Specialist, Pharmacy Operations
Cardinal Health
Houston, Texas

Breanna Spires, BBA, CPhT
Administrative Officer for the Chief Nurse of Primary Care
Carl Vinson VA Medical Center
Dublin, Georgia


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

All planners, presenters, and reviewers of this session report no financial relationships relevant to this activity.

Methods and CE Requirements

Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.